Observed Signal · Aug 24, 2026 · Market Signal · Source: Galderma · Impact: 4/5
Galderma opens new U.S. and Latin America headquarters in Miami
Track Galderma Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies
Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies. Also: Galderma's Restylane® Volyme™ demonstrates high effectiveness in Chinese patients; Galderma opens new U.S. and Latin America headquarters in Miami.
Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies
Galderma has been added to the Swiss Market Index (SMI), marking its inclusion among Switzerland's leading blue-chip companies. This is a major corporate milestone for the company.
Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older
Galderma's latest press release announces new three-year data for Nemluvio® in atopic dermatitis, presented at Fall Clinical 2026.
Receive all future signals for Galderma & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.